Treatment of Perioral Dermatitis
For perioral dermatitis, the first-line treatment is oral tetracyclines for adults, while topical treatments including metronidazole, erythromycin, or pimecrolimus are recommended for children and cases where oral therapy is contraindicated. 1, 2
Understanding Perioral Dermatitis
Perioral dermatitis is an acneiform facial eruption characterized by:
- Erythematous papules, pustules, and papulovesicles
- Typically affects the perioral region with a characteristic spared zone around the vermilion border
- Can also involve perinasal and periorbital areas (periorificial dermatitis)
- More common in women aged 15-45, though children can be affected (especially boys in the granulomatous form) 3
Treatment Algorithm
First Step: Eliminate Contributing Factors
- Discontinue all topical corticosteroids (most common trigger)
- Stop using heavy facial moisturizers, cosmetics, and fluoridated toothpaste
- Consider "zero therapy" (avoidance of all facial products) for mild cases 3, 2
For Adults:
First-line: Oral tetracyclines
- Tetracycline 500mg twice daily or doxycycline 100mg daily
- Continue until complete remission (typically 4-8 weeks)
- Strongest evidence supports this approach 2
Topical options (for mild cases or as adjuncts):
For Children (under 8 years):
First-line: Topical treatments
- Metronidazole 0.75-1% gel/cream
- Erythromycin 2% solution/gel
- Pimecrolimus 1% cream 4
For moderate to severe cases:
- Oral erythromycin 30-50 mg/kg/day divided into 3-4 doses 4
For Refractory Cases:
- Consider oral isotretinoin for severe, resistant cases 3
- β-lactam antibiotics (like cefcapene pivoxil) may be effective, particularly when fusobacteria are involved 5
Managing Steroid-Induced Cases
When perioral dermatitis is induced by topical corticosteroids:
- Immediate discontinuation of the corticosteroid is essential
- Warning: Expect a rebound flare after discontinuation
- Management options:
- Gradual tapering by reducing potency and frequency
- Pimecrolimus has shown particular efficacy in reducing severity during this transition 2
- Consider short-term oral tetracycline to manage the rebound inflammation
Special Considerations
- Pregnancy: Avoid tetracyclines; consider topical treatments or erythromycin
- Children under 8: Avoid tetracyclines due to dental staining risk; use topical agents or oral erythromycin
- Duration of therapy: Continue until complete clearance, typically 4-12 weeks
- Maintenance: After clearance, gentle skin care with non-comedogenic, fragrance-free products
Monitoring and Follow-up
- Follow up within 2-4 weeks to assess response
- If no improvement after 4 weeks of appropriate therapy, reconsider diagnosis
- Counsel patients about the chronic nature of the condition and possible recurrence
Remember that perioral dermatitis can be stubborn and may require several months of treatment. Patient education about avoiding triggers and adhering to therapy is crucial for successful management.